CCR5 antagonist reduces HIV-induced amyloidogenesi
Post# of 147702
Quote:
CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
https://pubmed.ncbi.nlm.nih.gov/34809709/
Quote:
Entanglement of CCR5 and Alzheimer’s Disease
https://www.frontiersin.org/articles/10.3389/...00209/full